Latest News

Rates of food insecurity remain high in American Indian communities, and a recent study indicates that inadequate food quality and quantity may put these populations at higher risk of diabetes, obesity, and hypertension.
Jonathan Hirsch Discusses Challenges in Health IT Implementation
The state of current software systems, primarily electronic medical records, is a significant barrier to implementing successful health IT tools, said Jonathan Hirsch, founder and president of Syapse. He also explained some of the solutions developed by Syapse to address these challenges, like improving the software’s integration capabilities and making it more usable for providers.
After his inauguration, President Donald J. Trump signed an executive order ordering federal agencies to ease the burden of his predecessor’s landmark healthcare law.
"Voluntary" is the key word in today's wellness programs, after EEOC rules were tested in court.
After great effort to resolve apparent conflicts between the ACA and older statutes, including the Americans with Disabilities Act, a repeal of the healthcare law may send regulators back to the drawing board.
Outgoing FDA Commissioner Robert Califf, MD, has announced that Richard Pazdur, MD, who was serving as the interim director, will now be heading the Oncology Center of Excellence.
This Week in Managed Care: January 20, 2017
This week, the top managed care stories included news that Republicans will introduce legislation to replace the Affordable Care Act, a report found the abortion rate hit a historic low, and results showed Januvia is safe for the oldest patients, even if they have cardiovascular risk.
A Big Data approach reveals the link between well-known insecticides and melatonin, a chemical that affects sleep patterns.
What we're reading, January 20, 2017: Minnesota will help residents with steep insurance premium hikes; the director of the National Institutes of Health appointed by President Barack Obama will stay on under the new administration; Anthem will end pre-authorization for opioid use disorder treatments.
Coverage of our peer-reviewed research in the healthcare and mainstream press.
A collaborative study has concluded that genomic assays can be successfully used to identify diagnostic, prognostic, and treatment-relevant alterations and can help guide precision treatment decisions for pediatric brain tumors.
Dr Katherine Schneider Says Adjusting to New Paradigm of Value Will Take Time
As the shift from volume-based care to value-based care continues, providers will require a whole new mindset and skillset to be successful, according to Katherine Schneider, MD, president of the Delaware Valley ACO.
The use of health information technology in small primary care practices continues to rise, but a recent study found that the extent of its adoption varies based on practice size, ownership, and financial incentives.
Observers have called the mini-pump, which continuously delivers exenatide, a "game changer" because it has the potential to overcome medication adherence in the patients who are most resistant to treatment.

From the Journals

At the 2016 annual meeting, the American Society of Hematology introduced the “Choosing Wisely Champions” to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures.
During the ASH Practice Partnership lunch, Joseph Alvarnas, MD, from the City of Hope, and editor-in-chief of Evidence-Based Oncology™ moderated a panel discussion on the impact of including nurse practitioners, physician assistants, and clinical nurse specialists into hematology care.
The Special Symposium on Quality looked at how health information technology (IT) can be utilized to improve healthcare quality, enhance patient–provider shared decision making, and facilitate efforts in quality research.
A joint session hosted by the American Society of Hematology and the European Hematology Association provided an update on the clinical progress with pluripotent stem cells.
Despite the complexities associated with treating older patients diagnosed with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), patients in the RESONATE-2 trial continue to present a favorable response to single-agent ibrutinib at a follow-up of 29 months.
The results showed that obinutuzumab-based immunochemotherapy and maintenance improved progression-free survival in treatment-naïve patients with follicular lymphoma.
A study in a mouse model found that mice receiving chimeric antigen receptor (CAR)-T immunotherapy plus ibrutinib demonstrated longer overall survival and reduced cytokine production than the mice not treated with ibrutinib.
The improved expansion of chimeric antigen receptor (CAR) T-cells indicates a deeper clinical response.
Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.
Compendia
COPD Compendium
Diabetes Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Managed Care Cast
Managed Care Cast
Healthcare 2020

NEW! Focus on 2020: What does the Future of Healthcare Hold?

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$